Výsledky vyhledávání

Akademický článek

Usefulness of dalbavancin in early discharge and non-hospitalization. It’s time to throw your heart over the obstacle?

Autor: Massimo Crapis, Sergio Venturini, Astrid Callegari, Giovanni Del Fabro, Igor Bramuzzo, Laura De Santi, Elisa Pontoni, Maurizio Tonizzo, Barbara Basso

Publikováno v: Global & Regional Health Technology Assessment, Vol 11, Iss Suppl. 2 (2024)

Introduction: Dalbavancin is a semisynthetic lipoglycopeptide long-acting antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Its features can be useful in the current healthcare scenario characteriz

Externí odkaz: https://doaj.org/article/a1d8b680171246b58bb40c4e74923b3e

Zobrazit plný text záznamu

Akademický článek

New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties

Autor: Andrea Lombardi, Laura Alagna, Emanuele Palomba, Giulia Viero, Anna Tonizzo, Davide Mangioni, Alessandra Bandera

Publikováno v: Transplant International, Vol 37 (2024)

Antimicrobial resistance is a growing global health problem, and it is especially relevant among liver transplant recipients where infections, particularly when caused by microorganisms with a difficult-to-treat profile, are a significant cause of mo

Externí odkaz: https://doaj.org/article/c0b3cd41d72f4dd1a911c9b9ec0570a2

Zobrazit plný text záznamu

Akademický článek

Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID

Autor: Giuseppe Ancona, Laura Alagna, Claudia Alteri, Emanuele Palomba, Anna Tonizzo, Andrea Pastena, Antonio Muscatello, Andrea Gori, Alessandra Bandera

Publikováno v: Frontiers in Immunology, Vol 14 (2023)

The gut microbiota plays a crucial role in human health and disease. Gut dysbiosis is known to be associated with increased susceptibility to respiratory diseases and modifications in the immune response and homeostasis of the lungs (the so-called gu

Externí odkaz: https://doaj.org/article/eae249406c1f4f0f9435e4ab1df5a8f5

Zobrazit plný text záznamu

Akademický článek

The Management of Recurrent Urinary Tract Infection: Non-Antibiotic Bundle Treatment.

Autor: Venturini, Sergio, Reffo, Ingrid, Avolio, Manuela, Basaglia, Giancarlo, Del Fabro, Giovanni, Callegari, Astrid, Tonizzo, Maurizio, Sabena, Anna, Rondinella, Stefania, Mancini, Walter, Conte, Carmina, Crapis, Massimo

Publikováno v: Probiotics & Antimicrobial Proteins; Oct2024, Vol. 16 Issue 5, p1857-1865, 9p

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients

Publikováno v: Biomedicines, Vol 11, Iss 6, p 1540 (2023)

Objectives: Monoclonal antibodies (mAbs) have proven to be a valuable tool against COVID-19, mostly among subjects with risk factors for progression to severe illness. Tixagevimab/cilgavimab (TIX/CIL), a combination of two Fc-modified human monoclona

Externí odkaz: https://doaj.org/article/5584c3bb01eb4035a1558b5eb7135686

Zobrazit plný text záznamu